Humanizing C3 in mice triggered C3 glomerulopathy (C3G), a complement-mediated kidney disease, because of impaired regulation of human C3 by mouse inhibitors, causing spontaneous complement activation (104). This evidence concerns the gene C3 and complement 3 glomerulopathy.